株式会社極東書店トップ > 商品一覧 > G Protein-Coupled Receptor Screening Assays: Methods and Protocols. Second Edition 2021
商品詳細
G Protein-Coupled Receptor Screening Assays: Methods and Protocols. Second Edition 2021
・ISBN 978-1-0716-1223-1 paper EUR 119.99
¥32,072.- (税込) ※(※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
お気に入り
★★★
| 著者・編者 | Martins, Sofia Aires M. / Prazeres, Duarte Miguel F. (eds.), |
|---|---|
| シリーズ | (Methods in Molecular Biology 2268) |
| 出版社 | (Springer-Verlag New York Inc., US) |
| 出版年月 | 2022 |
| ページ数 | 327 pp. |
| 言語 | ENG |
| ニュース番号 | <A02-74525> |
解説
This fully updated edition targets not only those assays directly involved in the discovery of GPCR-active compounds but also those involved in cell-based experiments designed to study physiological responses. Whether coming from academia or industry, or being an experienced researcher or a newcomer to the field, the reader will find accessible methods and protocols that cover the latest developments on receptor purification, molecular biology, recombinant engineering, and analytical techniques that enable the real time monitoring of the complex GPCR signaling cascade and identification of potential drug targets. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.
Authoritative and up-to-date, G Protein-Coupled Receptor Screening Assays: Methods and Protocols, Second Edition aims to provide the tools necessary to contribute to the advancement of GPCR research and discovery and ultimately lead to the availability of innovative and more efficient drugs.
Authoritative and up-to-date, G Protein-Coupled Receptor Screening Assays: Methods and Protocols, Second Edition aims to provide the tools necessary to contribute to the advancement of GPCR research and discovery and ultimately lead to the availability of innovative and more efficient drugs.